The keto diet protects against epileptic seizures. Scientists are uncovering why
The high-fat, low-carbohydrate ketogenic diet is more than just a trendy weight-loss tactic. It has also been known to help control seizures in children with epilepsy, particularly those who don ’t respond to first-line anti-seizure medications.In a new UCLA study published in the journalCell Reports, researchers demonstrate that the changes the diet causes in the human gut microbiome — the trillions of bacteria and other microorganisms that live in the digestive tract — can confer protection against seizures in mice.Understanding how the function of the microbiome is altered by the diet could aid in the development ...
Source: UCLA Newsroom: Health Sciences - December 15, 2023 Category: Universities & Medical Training Source Type: news
Why Some Myeloma Patients Refuse Stem Cell Transplant
(MedPage Today) -- A real-world analysis presented at the American Society of Hematology annual meeting showed that the refusal rate for autologous hematopoietic stem cell transplantation among patients with multiple myeloma is low, at about 2... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 15, 2023 Category: Hematology Source Type: news
This Frontline Therapy Is Better in Multiple Myeloma: Study This Frontline Therapy Is Better in Multiple Myeloma: Study
A study directly comparing real-world outcomes suggests patients with transplant-ineligible multiple myeloma do better with frontline triple therapy with daratumumab vs bortezomib.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 14, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
KDIGO Supports HCV+ Kidneys Going To HCV – Recipients KDIGO Supports HCV+ Kidneys Going To HCV – Recipients
" This update is intended to assist clinicians in the care of patients with HCV infection and CKD, including patients receiving dialysis (CKD G5D) and patients with a kidney transplant (CKD G1T-G5T). "MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 13, 2023 Category: Consumer Health News Tags: Nephrology Source Type: news
No Benefit to Salvage Transplant in R/R Multiple Myeloma No Benefit to Salvage Transplant in R/R Multiple Myeloma
Long-term follow-up shows no progression-free or overall survival advantage among patients who received salvage transplant vs continuous lenalidomide plus dexamethasone.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 13, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Sickle Cell: Good Outcomes for Haploidentical Transplants Sickle Cell: Good Outcomes for Haploidentical Transplants
It is much easier to find eligible haploidentical donors — half-matched or partially matched — than eligible hematopoietic donors.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 13, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
ASH: Daratumumab Beneficial for Patients With Multiple Myeloma
WEDNESDAY, Dec. 13, 2023 -- For transplantation-eligible patients with newly diagnosed multiple myeloma, the addition of subcutaneous daratumumab combined with bortezomib, lenalidomide, and dexamethasone induction and consolidation therapy and with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 13, 2023 Category: Pharmaceuticals Source Type: news
'Half-Matched' BMTs Effective in Severe Sickle Cell Disease
(MedPage Today) -- SAN DIEGO -- A reduced-intensity "half-matched" bone marrow transplant (BMT) protocol demonstrated durable donor engraftment, with encouraging survival rates, in adults with severe sickle cell disease (SCD) for whom stem cell... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 13, 2023 Category: Hematology Source Type: news
Dengue Fever Is Soaring Worldwide. Here ’s What to Know—and How to Stay Protected
Governments and public health experts around the world are sounding the alarm about the record-high spread of one of the most notorious—and incurable—diseases, which about half the world is at risk of catching: dengue.
The mosquito-borne virus has a long history in warm climates but is now also emerging in regions where it had been generally unheard of—such as in Europe and parts of the U.S. By early December, there had already been more than five million dengue infections worldwide this year—a dramatic increase from some 500,000 cases in 2000—recorded across at least 80 countries and terri...
Source: TIME: Health - December 13, 2023 Category: Consumer Health News Authors: Koh Ewe Tags: Uncategorized Explainer News Desk Source Type: news
MRD Status Predicts Transplant Benefit in NPM1-Mutated AML MRD Status Predicts Transplant Benefit in NPM1-Mutated AML
MRD-positive patients in first complete remission after induction therapy had a survival benefit after transplant; however, that benefit did not extend to MRD-negative patients after transplant.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 12, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
MRD Tied to Allo-Transplant Benefit in NPM1-Mutated Acute Myeloid Leukemia
(MedPage Today) -- SAN DIEGO -- Measurable residual disease (MRD) after induction therapy can guide the use of allogeneic transplant in patients with NPM1-mutated acute myeloid leukemia (AML) in first remission, regardless of whether FLT3 internal... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 11, 2023 Category: Hematology Source Type: news
Medscape Now! Hot Topics in Women ’s Health December 2023 Medscape Now! Hot Topics in Women ’s Health December 2023
Find out about how gender impacts outcomes in PTSD and cardiogenic shock.Medscape Education Clinical Briefs (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - December 11, 2023 Category: Transplant Surgery Tags: Ob/Gyn & Women ' s Health Clinical Brief Source Type: news
New data for Roche ’s Columvi and Lunsumio presented at ASH 2023 support continued benefit for people with lymphoma
Longer-term data from pivotal studies of fixed-duration Columvi and Lunsumio continue to show durable responses in people with heavily pre-treated lymphomas1,2New data reinforce the potential of combination regimens in earlier treatment settings and add to the robust body of evidence supporting ongoing Phase III studies3,4,5,6Basel, 11 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data from its CD20xCD3 T-cell engaging bispecific antibody programme, including eight oral presentations, were presented at the 65th American Society of Hematology (ASH) Annual Meeting& Exposition, 9-12 December ...
Source: Roche Media News - December 11, 2023 Category: Pharmaceuticals Source Type: news
New data for Roche ’s Columvi and Lunsumio presented at ASH 2023 support continued benefit for people with lymphoma
Longer-term data from pivotal studies of fixed-duration Columvi and Lunsumio continue to show durable responses in people with heavily pre-treated lymphomas1,2New data reinforce the potential of combination regimens in earlier treatment settings and add to the robust body of evidence supporting ongoing Phase III studies3,4,5,6Basel, 11 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data from its CD20xCD3 T-cell engaging bispecific antibody programme, including eight oral presentations, were presented at the 65th American Society of Hematology (ASH) Annual Meeting& Exposition, 9-12 December ...
Source: Roche Investor Update - December 11, 2023 Category: Pharmaceuticals Source Type: news
Tampa General Hospital to break ground on 13-story expansion in 2024
The hospital's plan to build the TGH Surgical, Neuroscience and Transplant Pavilion on its Davis Islands campus has received unanimous approval from Tampa City Council. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 11, 2023 Category: Pharmaceuticals Authors: Ashley Gurbal Kritzer Source Type: news
